This accuracy is close to the minimum recommended for a useful diagnostic test for neurodegenerative diseases.27 That the correlation between PD2 levels and UPDRS scores remained highly significant when controlled for amounts of dopaminergic medications suggests that this antibody is a marker of underlying disease pathology rather than an artifact of dopaminergic treatment. The gene discussed is PAF1; the disease is neurodegenerative disease.